193 related articles for article (PubMed ID: 36893780)
1. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
Aokage K; Suzuki K; Saji H; Wakabayashi M; Kataoka T; Sekino Y; Fukuda H; Endo M; Hattori A; Mimae T; Miyoshi T; Isaka M; Yoshioka H; Nakajima R; Nakagawa K; Okami J; Ito H; Kuroda H; Tsuboi M; Okumura N; Takahama M; Ohde Y; Aoki T; Tsutani Y; Okada M; Watanabe SI;
Lancet Respir Med; 2023 Jun; 11(6):540-549. PubMed ID: 36893780
[TBL] [Abstract][Full Text] [Related]
2. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
[TBL] [Abstract][Full Text] [Related]
3. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Saji H; Okada M; Tsuboi M; Nakajima R; Suzuki K; Aokage K; Aoki T; Okami J; Yoshino I; Ito H; Okumura N; Yamaguchi M; Ikeda N; Wakabayashi M; Nakamura K; Fukuda H; Nakamura S; Mitsudomi T; Watanabe SI; Asamura H;
Lancet; 2022 Apr; 399(10335):1607-1617. PubMed ID: 35461558
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
5. A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211).
Aokage K; Saji H; Suzuki K; Mizutani T; Katayama H; Shibata T; Watanabe S; Asamura H;
Gen Thorac Cardiovasc Surg; 2017 May; 65(5):267-272. PubMed ID: 28255781
[TBL] [Abstract][Full Text] [Related]
6. Comparison of surgical outcomes and prognosis between wedge resection and simple Segmentectomy for GGO diameter between 2 cm and 3 cm in non-small cell lung cancer: a multicenter and propensity score matching analysis.
Zhou Y; Yu T; Zhang Y; Qian L; Xia Q
BMC Cancer; 2022 Jan; 22(1):71. PubMed ID: 35034626
[TBL] [Abstract][Full Text] [Related]
7. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
[TBL] [Abstract][Full Text] [Related]
8. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
Yoshioka M; Ichiguchi O
Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
[TBL] [Abstract][Full Text] [Related]
9. [JCOG lung cancer surgery trial series: review and interpretation].
Li RZ; Qiu B
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):703-711. PubMed ID: 35880335
[TBL] [Abstract][Full Text] [Related]
10. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
11. Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer?
Mimae T; Okada M
Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):703-706. PubMed ID: 31691886
[TBL] [Abstract][Full Text] [Related]
12. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
Suzuki K; Watanabe SI; Wakabayashi M; Saji H; Aokage K; Moriya Y; Yoshino I; Tsuboi M; Nakamura S; Nakamura K; Mitsudomi T; Asamura H;
J Thorac Cardiovasc Surg; 2022 Jan; 163(1):289-301.e2. PubMed ID: 33487427
[TBL] [Abstract][Full Text] [Related]
13. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of segmental resection in non-small-cell lung cancer with ground-glass opacity.
Iwata H; Shirahashi K; Mizuno Y; Yamamoto H; Takemura H
Eur J Cardiothorac Surg; 2014 Sep; 46(3):375-9; discussion 379. PubMed ID: 24562008
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
[TBL] [Abstract][Full Text] [Related]
16. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
[TBL] [Abstract][Full Text] [Related]
18. A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
Kamigaichi A; Hamada A; Tsuboi M; Yoshimura K; Okamoto I; Yamamoto N; Tsutani Y
Clin Lung Cancer; 2024 Jun; 25(4):384-388.e1. PubMed ID: 38360496
[TBL] [Abstract][Full Text] [Related]
19. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
Kamigaichi A; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
Clin Lung Cancer; 2019 Sep; 20(5):397-403.e1. PubMed ID: 31281050
[TBL] [Abstract][Full Text] [Related]
20. Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size.
Hattori A; Matsunaga T; Fukui M; Takamochi K; Oh S; Suzuki K
Interact Cardiovasc Thorac Surg; 2022 Nov; 35(6):. PubMed ID: 36161317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
